A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/R WITH OR WITHOUT DASABUVIR AND WITH OR WITHOUT RIBAVIRIN IN CHRONIC HEPATITIS C VIRUS GENOTYPE 1 OR 4 INFECTED ADULTS WITH SUCCESSFULLY TREATED EARLY STAGE HEPATOCELLULAR CARCINOMA: